Primovist Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

primovist

bayer new zealand limited - gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) - solution for injection - 181.43 mg/ml - active: gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) excipient: hydrochloric acid as 3.6% w/w aqueous solution caloxetate complexing agent sodium hydroxide trometamol water for injection - for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesions

MULTIHANCE Իսրայել - անգլերեն - Ministry of Health

multihance

dexcel ltd, israel - gadobenic acid as dimeglumine salt - solution for injection - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.• mri of the breast, for the detection of malignant lesions in patients where breast cancer is known or suspected on the basis of previous mammography or ultrasound results